Cargando...

Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?

The act of nonmedical switching, defined as switching stable patients who are generally doing well with their current therapy from an originator biologic to its biosimilar, has been endorsed as a reasonable treatment strategy. The safety and efficacy of nonmedical switching have been evaluated in ra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Rheumatol Ther
Autores principales: Fleischmann, Roy, Jairath, Vipul, Mysler, Eduardo, Nicholls, Dave, Declerck, Paul
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Healthcare 2020
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7021884/
https://ncbi.nlm.nih.gov/pubmed/31950442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-019-00190-7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!